Functional constipation symptoms and complementary feeding methods: A randomized clinical trial

Renata Oliveira Neves1, Leandro Meirelles Nunes2, Larissa de Oliveira Silveira3

  • 1Programa de Postgrado en Salud Infantil y Adolescente, Facultad de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Río Grande del Sur, Brazil.

Anales De Pediatria
|March 15, 2023
PubMed

Insights

Introducing solid foods to infants did not impact constipation. This study found no link between parent-led weaning, Baby-led Introduction to SolidS (BLISS), or mixed approaches and infant constipation symptoms at 12 months.

Area of Science:

  • Pediatrics
  • Infant Nutrition
  • Gastroenterology

Background:

  • Functional constipation is a common concern in infants.
  • Complementary feeding practices are believed to influence infant gut health.
  • Understanding the impact of different feeding methods is crucial for infant well-being.

Purpose of the Study:

  • To evaluate the effect of three complementary feeding methods on functional constipation in 12-month-old infants.
  • To compare parent-led weaning (PLW), Baby-led Introduction to SolidS (BLISS), and a mixed approach.
  • To determine if feeding method influences constipation prevalence.

Main Methods:

  • A randomized clinical trial involving 135 mother-infant dyads.
  • Infants were introduced to complementary foods at 5.5 months via PLW, BLISS, or a mixed approach.
  • Constipation symptoms were assessed at 12 months using Rome IV criteria via an online questionnaire.

Main Results:

  • The overall prevalence of constipation symptoms was 49.6%.
  • Constipation prevalence was 60% in the PLW group, 47.9% in the BLISS group, and 40.5% in the mixed approach group.
  • No statistically significant association was found between the complementary feeding method and functional constipation symptoms (P = .183).

Conclusions:

  • Functional constipation symptoms were highly prevalent in the studied infant population.
  • The chosen method for introducing complementary foods was not associated with the development of constipation symptoms.
  • Current complementary feeding strategies do not appear to influence the likelihood of infant constipation.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
261
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
212
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
381
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
265
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
507
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
246